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Abstract  
  Detection of influenza virus surveillance was world concerned for long time, because of series public health 
caused by the virus. In this study, rapid and sensitive methods of direct immunofluorescence assay (DFA) and 
the real time quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to detect and 
distinguish between influenza virus type A and B in children, with influenza like illness symptoms, of age 
ranged between 2 months and 5 years old in two children hospitals in Baghdad city.  Eight out of 100 (8%) 
children under investigation were found positive for influenza virus type A by using DFA while 13 (13%) was 
detected by RT–PCR. Whilst influenza B was completely absent in all individuals tested. In summary, influenza 
virus type A was moderately present (8%-13%) and absence of type B in population tested in Baghdad city by 
using serological and molecular assays. 
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1. Introduction 
One of the most important respiratory pathogens responsible for acute pneumonia worldwide is influenza virus 
type A and B. Only influenza virus type A has been responsible for pandemic influenza symptoms which known 
as H1N1 (Sonja et al .2008).  Infection with Influenza viruses vary from mild to severe, life threatening 
syndromes  and its  associated with divers clinical symptoms ranging from high fever > 38C°, cough, sour throat, 
runny nose and weakness. It may develop complications due to secondary bacterial infection or fatal 
complications as cute pneumonia and bronchitis (Cate 1987). However influenza symptoms share the same 
syndromes with other respiratory viral or other infectious in patients known as "influenza-like illness" (ILI) (Call 
et al. 2005). Influenza can be classified into three major types A, B and C according to antigen variation in their 
nucleoprotein (Mahony 2008) ,and the C type is much lesser extent. Influenza virus type A can be arranged into 
different subtypes based on the  antigen variation of hemagglutination and Neuraminidase proteins. These 
subtypes have been reported by World Health Organization (WHO) (WHO 2007). H1N1 the pandemic types 
which caused Swine Flu 2009; H5N1 caused Bird Flu 2004, H3N2 caused Hong Kong Flu 1968. In Northern 
Iraq, H5N1 was found in Erbil and Sulymanyia and it was confirmed with a fatal human case of infection, highly 
pathogenic H5N1 in poultry were reported in this area too. In addition, H1N1 caused epidemic during 2009 and 
2013 (WHO  2010;WHO  2013) . Therefore the threat of influenza viruses demand rapid and sensitive tools for 
detection in short time specially during pandemic periods. However, still immunofluorescence antibody staining 
and molecular technique such as conventional RT-PCR and qRT-PCR are most sensitive and rapid detection for 
respiratory viruses like influenza (WHO 2009). The aim of this study was to develop such assays for detection of 
influenza virus genotype A and B in children under 5 years old by using DFA and Reverse transcription chain 
reaction RT-PCR as routine laboratory assays.  
 
  2. Materials and methods  
One hundred of outpatient (infants) with influenza like illness (ILI) symptoms was tested for influenza virus, in 
two main children hospitals in Baghdad during the influenza season 2013-2014. Children with influenza like 
illness symptoms were defined with physical examination by the consultant physicians, chest X ray and signed 
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symptoms as running nose, fever, wheezing chest were cases of choice, together with detailed history such as 
sex, age for all patients recruited in this study.   
 
   2.1 Virus identification by direct immunofluorescence assay (DFA)   
   Specimens were processed to direct antigen detection according to manufacturer’s directions of the kit D³ 
FastPoint™ (Quidel, USA).  3ml of Nasal and throat clinical specimens were washed and suspended with 1x 
PBS several times, 2 drops of murine monoclonal antibodies  which directly labeled with R-phycoerythin and 
fluorescein isothiocyanate ( FITC) against influenza A/B was added to viral antigen in the washed epithelia cell.  
Stained cells  incubated at 35° to 37°C for 5-minutes, suspended pellets were rinsed with 1X PBS, and 
suspended with Re-Suspension Buffer, cells  loaded onto a specimen slide channel examined using a 
fluorescence microscope.   
 
 2.2 RNA Extraction  
 RNA extraction was done by using QIAamp Viral RNA Mini spin protocol (Qiagen, Hilden, Germany) was 
used for extraction assay. All samples were extracted according to the manufacturer's instructions. Briefly, 140µl 
of sample was extracted and loaded onto QIAamp Mini spin column and the highly- quality RNA were eluted in 
60 µL of buffer and stored at −70°C. 
   
2.3 Taqman primers and probes of Real Time RT-PCR  
  Invetrogen SuperScript™ III Platinum® one step kit was used to detect influenza virus type A and B according 
to the manufacture procedure of CDC (CDC, 2008). Universal primers and Black hole quencher probes were 
used for influenza A, F primer ‘5GAC CRA TCC TGT CAC CTC TGAC3’, R primer AGG GCA TTY TGG 
ACA AAK CGT CTA and probe sequence of influenza A was ‘5-FAM- TGC AGT CCT CGC TCA CTG GGC 
GAA -BHQ1-3’.Influenza B, F primer CGG TGC TCT TGA CCA AAT TGG, R primer, TCC TCA AYT CAC 
TCT TCG AGC G and Probe ‘5-FAM CCA ATT CGA GCA GCT GAA ACT GCG GTG-BHQI-3’.Cocktail of 
master mix, Tag polymerase , primers and probes prepared by mixing 12.5µl of 2xPCR master mix and equal 
volume 0.5 µl of Primers, probes and platium® Taq polymerase to get total volume 20 µl. 5µl of extracted RNA 
PCR was performed using Applied Biosystem 7500 (Applied Biosystem, Singapore) as follow: for 45 cycles , 
Reverse transcriptase 50C  30 mints, Taq inhibitors activation 95C 2 mints, PCR amplification 95C ,15 sec and 
data collection was at 55C for 30 sec. 
 
    3. Results   
3.1 Influenza like illness symptoms 
 Children who were enrolled in this study was between 3-5 days of fever duration temperature of 38-39⁰C 
The clinical symptoms of ILI associated with influenza virus was (80%) for fever, (72%) sore throat, (84%) 
cough, (76%) rhinorrhea, (78%) wheezing chest Table 1. P value for symptoms were positively correlated with 
flu like illness P<0.01, as well as the correlation coefficient r =0.97. The positive predictive value of influenza 
syndrome PPV was range from (0.1- 0.13) for fever, sour throat, cough, rhinorrhea and wheezing chest compare 
with ILI .The negative predictive value range from (0.94- 0.98) for the same symptom respectively. Prevalence 
of laboratory-confirmed cases using clinical criteria of influenza-like illness was 13% by using both DFA and 
RT- PCR. The specimens in this study were obtained from nasal and throat, and they were sufficient and 
consider reliable for detection influenza virus. Because swab technique considered as best choice for many 
medical laboratories concerned with influenza surveillance during influenza season infection among children.  
 
 3.2 Detection of Influenza virus genotype A & B 
 Results of influenza virus A and B by using D³ FastPoint L-DFA found that 8 of 100 clinical specimens were 
positive of influenza A virus Figure 1. While genotype B disappeared in all the tested specimens Table 2. The 
quality of the sample was assessed by observing the number of respiratory epithelial cells present as well as 
repeating poor quality samples. The sensitivity and the specificity of the test estimated according to sensitivity 
and specificity formula described by Rajul et al. (2008), and were shown to be 66% sensitivity and 96% 
specificity. 
 
 3.3 Detection of influenza genotype A&B by RT-PCR. 
  Detection by RT-PCR showed that 13 children of 100 were infected with influenza virus genotype A. The 
detection for influenza virus genotype B was found negative in the entire tested specimens. The threshold cycle CT 
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values for Influenza genotype A were between (19.6- 35.9), which considered with range of strong to moderate of 
viral amount in the sample Figure 2. The influenza virus A was found in children with ILI age between two months 
and two years old, with rate of infection 2 months to 1 year 5%, 1- 2 years 7%, 2-5 years 1%, Table 3. 
 
 4. Discussion 
  In general, the ILI clinical symptoms of influenza in children are similar to other respiratory pathogens cause 
respiratory infection during the influenza activity season. Laboratory-confirmed influenza illness with simple 
clinical symptoms using rapid influenza test, would have identified 74% - 88% of the influenza infection among 
children Matthew et al. (2010) and CDC (2009). Never the less, using rapid diagnostic test DFA in this study 
was able to detect 8 of influenza A positive infections. Many studies show that cough, high fever and sour throat 
are likely to be common symptoms for influenza virus infection Monto et al. (2000). The influenza like illness in 
this study showed well correlation with influenza activity during the infection season. This result is in agreement 
with Monto et al. (2000) and Jose et al. (2005) which determined that the symptoms and clinical observation 
might be good indictors for diagnosis influenza infection than the other illness due to respiratory viruses. The 
prevalence of influenza virus among children under five in this study was in agreement with Samransamruajkit 
et al.( 2008)  and  Muyembe et al. (2012) in Japan and Democratic Republic of Conge 12.5%, and 15% 
respectively.  The specificity and sensitivity of using DFA for influenza virus diagnosis of this technique is in 
agreement with James et al. (2003) as has been demonstrated that the sensitivity range was from 39% -76% for 
adults and 56 - 66% for infants, while the specificity range was 94%-99% by using (DFA, direct fluorescent 
antibody) kit and other immunoassay methods for the detection of influenza. specificity and sensitivity  effected 
by other factors such as specificity of the reagents, patients age, certain genotypes and the level of experience of 
those performing, reading, and interpreting the test Weinberg & Walker (2006). It has been argued that the 
sensitivity of those tests in general is higher in children compared to adults because, children shed more viruses 
and for longer period than adults (WHO 2005). Using DFA in this study appeared to be mostly reliable except in 
a few cases there was some false positive or negative and this may be due to clarity of (unclear) fluorescence of 
cells or accumulation of stain debris after insufficient washing by buffer. Gavin & Thomson (2003)  attributed 
the reason for the false negative results of some specimens due to the lack of adequate numbers of respiratory 
epithelial cells in the specimen and non-specific florescence of cells, debris which can produce false-negative 
result or false-positive, respectively. However, DFA is still recommended as a reliable method for diagnosis of 
influenza virus for inpatients and outpatients in many international medical laboratories and hospitals. Although 
none of the  direct immunofluorescence assay - rapid influenza A tests can differentiate genotype A virus 
subtypes or discriminate between those subtypes that commonly infect humans such as H3N2 and H1N1(CDC 
2005). Rapid tests are usually useful for guiding treatment and patient management in a clinically relevant 
timeframe as approved by (CDC 2006).  RT-PCR molecular technique considered one of the important tools that 
used for rapid and sensitive detection during the epidemic outbreak because of the primers and probes which 
designed specifically for differentiating novel influenza A viruses H1N1, and for typing influenza A and B virus, 
as well as subtyping H1, H2, H3, H5, H7, H9, N1 (human and animal), N2 or N7 of influenza Jie et al. (2009). 
On the other hand CDC universal influenza genotype A primers and probes were used in our study seem to be 
reliable for detection influenza genotype A in ILI patients. These results are similar to previous studies using the 
same technique of real-time PCR] Bo et al. (2011). This efficient technique is based on a Taqman technology, in 
which a probe is designed to hybridize to an internal region of the PCR product so that the highest sensitivity and 
specificity can be achieved during the PCR amplification. Results of this part of the study also agree with 
Nathamon et al. (2010) as they identify influenza genotype A with the same sets of primers that we used as they 
derived from the most conserved region of influenza matrix protein (M) gene Bo, Shu et al. (2011). On the other 
hand, influenza virus genotype B was not detected by using RT-PCR, it may be due to the lower transmission 
rate of influenza virus genotype B  which is consider slower than influenza virus genotype A. Genotype B is 
known of its ability to transmit from human to human only. In addition, the rate of mutation is 3-4 times lower 
than influenza virus genotype A Nobusawa & Sato (2006).  Khanna et al. (2008) demonstrated that all influenza 
B infection outbreaks are only found as regional epidemics. So that may give another explanation to this 
observation especially no relevant data about influenza virus genotype B was reported in our region (Middle-
East). Furthermore, the WHO annual reports about seasonal influenza in Iraq did not indicate any significant 
numbers of infections with this genotype, except a very small number of infections reported in some Asian 
countries (outside our region) (WHO 2006; WHO 2014). However, some related studies by Harvala et al. (2014) 
in Europe reported circulating influenza genotype B among children population under 5 years old of more than 
5% infection per 100,000. Other explanation may be attributed to the duration of shedding of avian Influenza 
genotype A and B viruses in which is humans is not known yet. Therefore the estimated duration of viral 
shedding is based upon seasonal influenza virus A infection which is estimation 5% -10% in adult and 20%-30% 
in children while Influenza genotype B is only 5% (WHO 2014).  
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5. Conclusion  
 In brief conclusion was found that that the circulating genotypes among children with influenza like illness (ILI) 
symptoms in children less than five years old, was influenza virus genotype A. Influenza virus genotype B was 
not detected in this cohort of patients.  DFA and RT-PCR found reliable methods fast, accurate and sensitive for 
diagnosis of influenza A virus surveillance. And it may need to be developed in the future for fast and accurate 
identification of any novel influenza virus subtypes 
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Table 1. Clinical symptoms for children infected with influenza like illness collected from children > 5 years by 
using nasal and throat swabs. 
Code of the 
samples 
Age Sex Fever 
over 38c 
Cough Sore 
throat  
Runny 
nose  
Difficulty 
breathing 
Wheezing
 ILI-1 3 months M  −− √ −− √ √ √ 
 ILI-2 7 months M  √ −− √ √ −− −− 
 ILI-3 2 years F  √ √ √ √ √ √ 
 ILI-4 4 years F  √ −− √  −−  −− −− 
 ILI-5 3 months M √ √  √ √ √  √  
ILI-6 5 years M  √ −− −− √ −− −− 
ILI-7 3 months F  √ √ √ −−  √ √ 
ILI-8 4 months M  √ √ √ √ √ √ 
ILI-9 4 years M  √ √ −− √ √ √ 
ILI-10 4 months F  √ −− −− √ −− −− 
ILI-11 2,6 years F  √ √ √ √ √ √ 
ILI-12 3 years F  √ √ √  −− √ √ 
ILI-13 11 month M  √ √ √ √ √ √ 
ILI-14 5 years M  −− √ −− √ −− −− 
ILI-15 4 years M  −− √ √ √ −− −− 
ILI-16 4 years F  −− √ √ √ −− −− 
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ILI-17 7 months F  √ √ √ −−  √ √ √ 
ILI-18 8 months M  √ √ √  −−  √ √ √ 
ILI-19 4 months M  √ √ −− √ √ √ √ 
ILI-20 1 year M  √ −− −− √ −− −− √ 
ILI-21 2 years  F  √ √ √ √ √ √ √ 
ILI-22 2 months F  √ √ −− √ √ √ √ 
ILI-23 2 years F  √ √ √ √ √ √ √ 
ILI-24 2 years M  √ √ √ −−  √ √ √ 
ILI-25 5 years M  √ √ √ √ √ √ √ 
ILI-26 2 years  F  √ −− √ √ −− −− −− 
ILI-27 3 years  F  √ −−  −− √ −− −− −− 
ILI-28 1,4 year M  √ −− −− √ −− −− −− 
ILI-29 1 year M  √ √ √ √ √ √ √ 
ILI-30 4 months  M  √ √ √ −−  √ √ √ 
ILI-31 2 years F √ −−   −− √ −− −− −− 
ILI-32 1 year M  −− −−  −− √ −− −− −− 
ILI-33 2 years M  √ √ √ √ √ √ √ 
ILI-34 11 months M  √ −− √ −−  −− −− −− 
ILI-35 5 years F √ √ −− √ √ √ √ 
 
Code of 
the 
samples 
Age Sex Fever 
over 38c 
Cough Sore 
throat  
Runny 
nose  
Difficulty 
breathing 
Wheezing Chest 
X ray
ILI-36 1 year F  −− √ −− √ −− −− 
ILI-37 1,3  year F  −− √ √ √ √ √ 
ILI-38 2 years M  √ √ √ −− √ √ 
ILI-39 1,4 year F  −− √ −− √ √ √ 
ILI-40 9 months M  −− √ −− √ √ √ 
ILI-41 5 years M  √ √ √ −− √ √ 
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ILI-42 1 year M  √ √ √ √ √ √ √ 
ILI-43 1,4 year M  √ −− √ √ −− −− −− 
ILI-44 2 years M  √ √ √ √ √ √ √ 
ILI-45 9 months M  √ √ √ −− √ √ √ 
ILI-46 5 months M   −− √ −−  √ √ √ √ 
ILI-47 9 months F  √ √ √ √ √ √ √ 
ILI-48 6 months M  √ √ √ √ √ √ √ 
ILI-49 1,2 year M  √ √ √ −− √ √ √ 
ILI-50 3 years F  −−  √ −− √ √ √ √ 
ILI-51 1,8 year M  √ √ −− √ √ √ √ 
ILI-52 5 years F  √ √ √ √ √ √ √ 
ILI-53 4 months F  √ √ √ √ √ √ √ 
ILI-54 1,7  year M  √ √ √ −− √ √ √ 
ILI-55 3,6 years F  √ √ √ √ √ √ √ 
ILI-56 3 months F  √ −− √ √ −− −− −− 
ILI-57 2 years F  √ √ √ √ √ √ √ 
ILI-58 1,6 year M  √ √ −− √ √ √ √ 
ILI-59 5 years F  √ √ √ √ √ √ √ 
ILI-60 4 years F  √ √ √ −− √ √ √ 
ILI-61 1,8  year F   √ √ √ √ √ √ √ 
ILI-62  9 months M  √ √ √ √ √ √ √ 
ILI-63  3 years   F √ √ √ −−  √ √ √ 
ILI-64 6 months F √ √ √ √ √ √ √ 
ILI-65 3 years M √ √ √ √ √ √ √ 
ILI-66 11  months M √ √ √ −−  √ √ √ 
ILI-67 3 years M  √ √ √ √ √ √ √ 
ILI-68  1,9 year M  √ −− √ √ −− −− −− 
ILI-69 16 months F  −− √ −− √ √ √ √ 
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ILI-70 3,6 years F  −−  √  −− √ √ √ √ 
ILI-71 5 months F  √ √ √ √ √ √ √ 
ILI-72 1,2  year F  √ √ √ −− √ √ √ 
ILI-73 1.2 year F  √ √ √ √ √ √ √ 
ILI-74 2 years M  −− √ −− √ √ √ √ 
ILI-75 2 years  M  −− √ −− √ √ √ √ 
 
Code of the 
samples 
Age Sex Fever 
over 38c 
Cough Sore 
throat  
Runny 
nose  
Difficulty 
breathing 
Wheezing
ILI-76 2 months M  √ √ √ √ √ √ 
ILI-77 5 years F  √ √ √ √ −− −− 
ILI-78 5 months M  √  −− √  −−  −− −− 
ILI-79 3 years F  −− −− −− √ −− −− 
ILI-80 1,6 year F  −− √ √ √ √ √ 
ILI-81 1 year M  √ √ √ √ √ √ 
ILI-82 5 years F  √ √ √ −−  √ √ 
ILI-83 2 years F  √ √ √ −− √ √ 
ILI-84 7 months M  √ √ √ √ √ √ 
ILI-85 7 months M  −−  √  −− √ √ √ 
ILI-86 3,6 years M  √ √ √ √ √ √ 
ILI-87 5 months M  √ √ √ √ √ √ 
ILI-88  2,6 years M  √ √ √ −− √ √ 
ILI-89 2 years F  √ √ √ √ √ √ 
ILI-90 1,6 year M  √ √ √ √ √ √ 
ILI-91 1,7 year M  √ √ √ −−  √ √ 
ILI-92 2 years M  √ √ √ √ √ √ 
ILI-93  3 years F  √ −− √ √ −− −− 
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ILI-94  3years M  −−  √ −−  √ √ √ 
ILI-95 9 months M  √ √ √ √ √ √ 
ILI-96 2,6 years  F √ √ √ −− √ √ 
ILI-97 1,6  year F  √ √ √ √ √ √ 
ILI-98 3 months F  −− √ −− √ √ √ 
ILI-99 1,5 year M  √ √ √ −−  √ √ 
ILI-100 2 years M  √ √ √ √ √ √ 
  
  
 
  
 
  
 
 
 
   
 
. 
 
 
   
  
 
 
 
 
 
 
 
Figure 1. Detection of influenza virus genotype A using direct immunofluorescent assay and D³ FastPoint 
method. A florescence microscope (BX61 Olympus) with 200X magnification were used  
A: negative control of influenza virus A and B;  
B: positive control of influenza virus A and B, (as they appear in golden color);  
C: positive result of influenza genotype A only.  
 
 
Table 2. Detection of influenza virus genotypes A and B in children and infant infected with influenza like 
illness (ILI) by D³FastPoint.   
B A 
C 
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Age Total specimens  
 evaluated (100) 
Influenza 
 A positive  
Influenza 
B positive  
>2months  to  
1 year  
  
37 2 non 
>1year to    
2 years  
  
35 6 non 
 >2  years to  
5 years  
 
28 0 non 
Total  100 8  0 
 
 
 
Figure 2. Profile of real-time RT-PCR amplification of influenza virus genotype A. CT value and thresholds of 
positive specimens from children between 2 months to 5 years old.  
 
 
 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.5, No.3, 2015 
 
221 
Table 3. Incidence of influenza virus genotype A and B in infant and young children. 
Age  No. of  specimens    No. of  Influenza
 virus A Infectio
  
 No. of  
Influenza  
virus   B infection
  
Rate of infection of influenza 
A 
>2months  to 1  1 year 
 
37 5 non 5% 
>1year to   2 years  
 
35 7 non 7% 
>2 years to 5 years  
 
28 1 non 1% 
Total  100 13  0 13% 
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